Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191.
Hay AE, Murugesan A, DiPasquale AM, Kouroukis T, Sandhu I, Kukreti V, Bahlis NJ, Lategan J, Reece DE, Lyons JF, Sederias J, Xu H, Powers J, Seymour LK, Reiman T. Hay AE, et al. Among authors: murugesan a. Leuk Lymphoma. 2016;57(6):1463-6. doi: 10.3109/10428194.2015.1091927. Epub 2015 Oct 15. Leuk Lymphoma. 2016. PMID: 26376958 Clinical Trial. No abstract available.
A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma.
Han M, Murugesan A, Bahlis NJ, Song K, White D, Chen C, Seftel MD, Howsen-Jan K, Reece D, Stewart K, Xie Y, Hay AE, Shepherd L, Djurfeldt M, Zhu L, Meyer RM, Chen BE, Reiman T. Han M, et al. Among authors: murugesan a. Blood. 2016 Aug 4;128(5):732-5. doi: 10.1182/blood-2016-06-716902. Epub 2016 Jun 23. Blood. 2016. PMID: 27338095 Free article. No abstract available.
Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10.
Grieve S, Ding K, Moore J, Finniss M, Ray A, Lees M, Hossain F, Murugesan A, Agar J, Acar C, Taylor J, Shepherd FA, Reiman T. Grieve S, et al. Among authors: murugesan a. ESMO Open. 2020 Mar;5(2):e000679. doi: 10.1136/esmoopen-2020-000679. ESMO Open. 2020. PMID: 32220948 Free PMC article.
Nanoparticle surface-enhanced Raman spectroscopy as a noninvasive, label-free tool to monitor hematological malignancy.
Grieve S, Puvvada N, Phinyomark A, Russell K, Murugesan A, Zed E, Hassan A, Legare JF, Kienesberger PC, Pulinilkunnil T, Reiman T, Scheme E, Brunt KR. Grieve S, et al. Among authors: murugesan a. Nanomedicine (Lond). 2021 Oct;16(24):2175-2188. doi: 10.2217/nnm-2021-0076. Epub 2021 Sep 22. Nanomedicine (Lond). 2021. PMID: 34547916 Free article.
A protocol to study the effect of targeted parental education intervention to identify early childhood development disorder - multisite interventional study.
Kanniappan V, Muthuperumal P, Venkataraman P, Murugesan A, Chinnasami B, Muthiah M, Sethuraman S, J R A, Suresh S, Nambirajan MK, G AG, T S V, Deivasigamani K. Kanniappan V, et al. Among authors: murugesan a. Arch Public Health. 2025 Jan 10;83(1):7. doi: 10.1186/s13690-024-01495-y. Arch Public Health. 2025. PMID: 39789580 Free PMC article.
Correction: Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors-Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India.
Selvavinayagam ST, Sankar S, Yong YK, Anshad AR, Chandramathi S, Somasundaram A, Palani S, Kumarasamy P, Azhaguvel R, Kumar AB, Subramaniam S, Malathi M, Vijayalakshmi V, Rajeshkumar M, Kumaresan A, Pandey RP, Muruganandam N, Gopalan N, Kannan M, Murugesan A, Balakrishnan P, Byrareddy SN, Dash AP, Velu V, Larsson M, Shankar EM, Raju S. Selvavinayagam ST, et al. Among authors: murugesan a. PLOS Glob Public Health. 2024 Dec 31;4(12):e0004157. doi: 10.1371/journal.pgph.0004157. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39739977 Free PMC article.
Modified Cajal's trichrome stain in oral squamous cell carcinoma.
Srinidhi SSV, Murugesan A, Balakrishnan S, Ramesh M, Varrshana V, Jacob M. Srinidhi SSV, et al. Among authors: murugesan a. J Oral Maxillofac Pathol. 2024 Jul-Sep;28(3):399-402. doi: 10.4103/jomfp.jomfp_542_23. Epub 2024 Oct 15. J Oral Maxillofac Pathol. 2024. PMID: 39670115 Free PMC article.
174 results